Figure 2. HLA haplotypes identified among the control group, Ebola survivors, and persons who died of Ebola virus disease in Guinea, 2015–2017. Percentage of each haplotype was calculated and defined as the number of persons with the HLA haplotype (n) divided by the number of individuals (N) in the studied group. Black boxes indicate presence of genes; white boxes indicate absence of genes. †p<Pc (survivors vs fatalities); ‡p<Pc (controls vs infected cases). HLA, human leukocyte antigen; NP, not present; Pc, corrected p value.